Total buying$00 buys
NRIX
Nurix Therapeutics, Inc.
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 09/19 to 10/19.
How these metrics are calculated
Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total selling$698k3 sells
Net open-market−$698kBuying minus selling
Active insiders3Distinct reporting owners
Insider activity report
Calendar-month buckets within the selected date range
Latest filing: Oct 15, 2026
Open-market transaction mix · 3 transactions in the selected period
Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.
View exact monthly counts and disclosed values
| Month | Buys | Sells | Awards (A) | Buy value | Sell value | Net P/S value |
|---|---|---|---|---|---|---|
| Sep 2026 | 0 | 0 | 0 | $0 | $0 | $0 |
| Oct 2026 | 0 | 3 | 0 | $0 | $698k | -$698k |
Distinct insiders active
Reporting-owner CIKs by month · peak Oct 2026 (3)Sep 2026Oct 2026
Largest insider activity
By absolute net disclosed value · current transaction page- GP-$486.5k
- RC-$83.7k
- HG-$33.6k
NRIX transaction history
Newest filings · 20 transactions per pageLatest insider transactions
Form 4 filings from last month.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
NRIXNurix Therapeutics, Inc. | Hansen GwennCSO | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
NRIXNurix Therapeutics, Inc. | Hansen GwennCSO | S · sale10b5-1 detectedSEC filing ↗ | -$36.3kView disclosure → | |
NRIXNurix Therapeutics, Inc. | Hansen GwennCSO | M · exercise10b5-1 detectedSEC filing ↗ | $2.70kView disclosure → | |
NRIXNurix Therapeutics, Inc. | Gregory Julia PDIR | M · exerciseDerivative securitySEC filing ↗ | $0View disclosure → | |
NRIXNurix Therapeutics, Inc. | Gregory Julia PDIR | S · saleSEC filing ↗ | -$528kView disclosure → | |
NRIXNurix Therapeutics, Inc. | Gregory Julia PDIR | M · exerciseSEC filing ↗ | $42.0kView disclosure → | |
NRIXNurix Therapeutics, Inc. | Ring ChristineCLO | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
NRIXNurix Therapeutics, Inc. | Ring ChristineCLO | S · sale10b5-1 detectedSEC filing ↗ | -$134kView disclosure → | |
NRIXNurix Therapeutics, Inc. | Ring ChristineCLO | M · exercise10b5-1 detectedSEC filing ↗ | $50.4kView disclosure → |
Filing-only signals
Deterministic matches in the selected period
Filing detail checks
Secondary metrics for the selected periodTransaction codes
By Form 4 transaction code in selected period9transactionstxns
- M · Option exercise · dominant6 · 67%
- S · Open-market sells3 · 33%
Activity by reported role
A joint filing can contribute to multiple rolesCLO3
CSO3
Director3
Reported Holdings After
Separated by insider, security, and ownership type
Ring ChristineCommon Stock · Direct
9,110Oct 02, 2026
Gregory Julia PCommon Stock · Direct
10,750Oct 14, 2026
Hansen GwennCommon Stock · Direct
117,227Oct 15, 2026
Ring ChristineEmployee Stock Option (right to buy) · Direct
111,251Oct 02, 2026
Gregory Julia PDirector Stock Option (right to buy) · Direct
0Oct 14, 2026
Hansen GwennEmployee Stock Option (right to buy) · Direct
59,406Oct 15, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells redSep 19 → Oct 19
LessMore
Nurix Therapeutics, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Nurix Therapeutics, Inc.?
Hansen Gwenn, GREGORY JULIA P, Ring Christine.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Hansen Gwenn reported a sale on Oct 15, 2026 valued at $36.3k. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $698,977.01. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.